Key Highlights of the Report: Several pharmaceutical companies is rapidly investing in research and development, thus driving the market growth during the forthcoming years. The high cost associated with the AAV gene therapy is one of the major challenge in its adoption among the patients. Increasing number of FDA approvals for AAV-based gene therapies, reflecting regulatory support and...

According to the UnivDatos, the surge in the incidences of rare genetic disorders and associated surge in the demand for targeted therapies will drive the global scenario of the rare genetic disorders treatment and as per their gene therapy market report, the global market was valued at USD 5663.1 million in 2022, growing at a CAGR of 30.1% during the forecast period from 2023 - 2030 to reach...